Core Insights - The new chief executive of the brewer is expected to implement strategies beyond just cost-cutting measures [1] Company Analysis - Analysts from TD Cowen suggest that the company must focus on more comprehensive strategies to enhance its performance rather than merely streamlining operations [1]

Shares of 3M Co. surged Tuesday toward a four-year high after the parent of Scotch tape, Post-it Notes and Command strips reported third-quarter results that rose above expectations, as the company bu... ...

Shares of Beyond Meat Inc. are soaring this week amid speculation that the struggling maker of pea-based meat substitutes might be joining the latest cohort of meme stocks. ...

Core Insights - Expanding horizons and considering neglected sectors can help identify bargain opportunities while protecting investment portfolios from stock-market declines [1] Group 1 - Exploring overlooked sectors may reveal undervalued investment opportunities [1] - Diversification into neglected areas can serve as a defensive strategy against market downturns [1]

Core Insights - The media giant, which owns brands like HBO and CNN, has received interest from multiple parties regarding a potential sale of all or part of the company [1] - The company's board is currently reviewing all options related to this interest [1]

Long-term economic growth depends on the old stepping aside to make way for the new. ...

The custom chip maker added a fourth customer that is expected to deliver $10 billion in revenue, and Mizuho analysts believe it could be OpenAI rival Anthropic. ...

Tesla will be riding one of its strongest delivery periods in history but will also have to face questions about its future in autonomy. ...

A J.P. Morgan analyst downgrades Goldman Sachs to neutral from overweight, saying Barclays and Deutsche Bank offer more potential upside. ...

Core Insights - Novo Nordisk, the maker of Ozempic, is undergoing significant changes in its board structure to enhance governance and strategic direction [1] Group 1: Company Changes - The company is appointing new board members to bring diverse expertise and perspectives [1] - These changes are part of a broader strategy to adapt to the evolving healthcare landscape and address shareholder concerns [1] Group 2: Market Impact - The restructuring is expected to strengthen Novo Nordisk's position in the competitive pharmaceutical market, particularly in diabetes and obesity treatments [1] - Investors are closely monitoring these developments as they may influence the company's future performance and stock valuation [1]